BEAM
Price
$20.17
Change
+$0.30 (+1.51%)
Updated
Apr 24 closing price
Capitalization
2.03B
18 days until earnings call
CLDX
Price
$19.57
Change
+$0.14 (+0.72%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.3B
6 days until earnings call
Ad is loading...

BEAM vs CLDX

Header iconBEAM vs CLDX Comparison
Open Charts BEAM vs CLDXBanner chart's image
Beam Therapeutics
Price$20.17
Change+$0.30 (+1.51%)
Volume$1.72M
Capitalization2.03B
Celldex Therapeutics
Price$19.57
Change+$0.14 (+0.72%)
Volume$11.93K
Capitalization1.3B
BEAM vs CLDX Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CLDX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and CLDX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BEAM: $20.17 vs. CLDX: $19.43)
Brand notoriety: BEAM and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 63% vs. CLDX: 73%
Market capitalization -- BEAM: $2.03B vs. CLDX: $1.29B
BEAM [@Biotechnology] is valued at $2.03B. CLDX’s [@Biotechnology] market capitalization is $1.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CLDX’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • CLDX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +18.65% price change this week, while CLDX (@Biotechnology) price change was +9.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

CLDX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.03B) has a higher market cap than CLDX($1.3B). BEAM YTD gains are higher at: -18.669 vs. CLDX (-23.091). CLDX has higher annual earnings (EBITDA): -191.9M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. CLDX (725M). CLDX has less debt than BEAM: CLDX (3.81M) vs BEAM (161M). BEAM has higher revenues than CLDX: BEAM (63.5M) vs CLDX (7.02M).
BEAMCLDXBEAM / CLDX
Capitalization2.03B1.3B156%
EBITDA-383.98M-191.9M200%
Gain YTD-18.669-23.09181%
P/E RatioN/AN/A-
Revenue63.5M7.02M905%
Total Cash851M725M117%
Total Debt161M3.81M4,222%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
63
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCLDX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 21 days ago
85%
Bearish Trend 17 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMIRX19.12N/A
N/A
Franklin International Equity R
HDGIX31.41N/A
N/A
Hartford Dividend and Growth I
STDFX35.64N/A
N/A
Allspring Large Cap Growth Admin
MIEDX8.47N/A
N/A
MassMutual International Eq R5
QCLGX21.46N/A
N/A
Federated Hermes MDT Large Cap Growth C

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
+0.23%
BEAM - CLDX
51%
Loosely correlated
+3.87%
DNLI - CLDX
51%
Loosely correlated
+1.85%
KYMR - CLDX
49%
Loosely correlated
+6.56%
NTLA - CLDX
48%
Loosely correlated
-2.65%
RVMD - CLDX
47%
Loosely correlated
+1.57%
More